slides · global inventory
Causal Chain
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,586
Current window 1,171-1,200
Pages 53
Rows per page 30
Framework
1,171-1,200 of 1,586
18
The slide uses a process-flow diagram to show the conversion of EBITDA to various cash flow metrics.Advantage Solutions | Investor Presentation Deck | 28 slides · Advantage Solutions
Pitch deck Investor relations Beat · Financials1 hit
41
The slide uses a simple linear process diagram to illustrate the core technology stack.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
99
The slide uses a causal chain structure to link technology adoption to financial and market outcomes.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank 1 hit
103
Uses a linear process flow to explain the business model mechanics.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank 1 hit
08
The slide uses a process-flow diagram to link acquisition inputs to financial outcomes.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
09
The slide uses a process-flow style diagram to show how different business levers contribute to the final outcome.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
38
The slide uses a custom process flow diagram to link EBITDA and conversion rates to dividend yield.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
05
Uses a causal chain/equation format to explain financial performance drivers.DraftKings | Results Presentation Deck | 16 slides · DraftKings
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
22
The slide uses a circular process diagram to show the feedback loop of immune cell activation and hair follicle damage.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
30
Includes a heatmap showing gene expression profiles under different cytokine conditions.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
25
The diagram shows the RAS/MAPK signaling pathway. The table provides a breakdown of patient populations for specific indications.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
55
The slide uses a biological pathway diagram to illustrate the mechanism of action.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
07
The slide uses a process flow at the bottom to illustrate the scaling initiative.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Beat · Interest1 hit
62
The slide uses a causal flow from technical capabilities (left) to strategic benefits (right).Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
40
Includes a biological pathway diagram and a honeycomb-style indication map.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
67
The slide uses a scientific mechanism-of-action argument to establish a competitive moat.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
12
Uses a simple additive equation structure to explain the drivers of long-term financial performance.Flutter | Results Presentation Deck | 47 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Interest1 hit
63
The slide uses a causal chain structure where three strategic initiatives lead to four business outcomes.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Jobs To Be Done1 hit
09
The slide uses a hub-and-spoke diagram to illustrate the central problem of CAR-T neurotoxicity and its four primary negative outcomes.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
32
Includes a scientific mechanism of action diagram showing iMX-110 effects on tumor microenvironment.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
12
The slide uses a process flow diagram to connect cellular pathology to clinical symptoms in the heart, liver, and kidneys.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
51
Includes a DepMap CRISPR sensitivity chart and a biological process diagram showing the MDM2-p53 feedback loop.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
52
The slide uses a biological pathway diagram to illustrate the mechanism of action and Western blot data to validate the claim.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
12
The slide uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a process diagram to illustrate the biological mechanism of action.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a waterfall-like structure to show the derivation of Adjusted EBITDA from Revenue.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
08
Includes a detailed biological pathway diagram and a Western blot image as evidence.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Solution1 hit
08
Includes a molecular pathway diagram and a Western blot image as evidence.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
17
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit